Malignant Neoplasms of Independent (Primary) Multiple Sites Clinical Trials

18 clinical trials for Malignant Neoplasms of Independent (Primary) Multiple Sites across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases — RECRUITING · PHASE1
• Prospective validation of Adaptive Radiotherapy in patients with head and neck tumors — RECRUITING
• A web-based psychosocial support program for families with Li-Fraumeni Syndrome or Fanconi Anemia: A brief feasibility study protocol — RECRUITING
• Psychosocial support needs of families with Li-Fraumeni syndrome (LFS) or Fanconi anaemia (FA) — RECRUITING
• OncoCoaching and early palliative care as patient-centered care elements in the therapy of incurable cancer — RECRUITING
• Assesment and optimising psychosocial care for persons with Li-Fraumeni syndrome and their relatives as part of the intensified screening and follow-up programme — RECRUITING
• Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT — ACTIVE_NOT_RECRUITING · PHASE1
• Expectations Regarding Mobility and Self-Care — ACTIVE_NOT_RECRUITING
• CoreNAVI - Feasability of a patient navigation programme — OTHER
• Acquisition of optical and olfactory sensory impressions directly during radiation therapy with protons or photons — OTHER
• Communication Strategies to Introduce Psychology Services — COMPLETED · NA
• Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic — COMPLETED
• The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms — WITHDRAWN · NA
• Wearable Exercise Trackers in Cancer Rehabilitation — COMPLETED · NA
• Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care Visit — COMPLETED · NA
• Effect of Physician Attire on Patients' Preference of Physician — COMPLETED · NA
• Difference in the Estimation of Prognosis — WITHDRAWN
• Lenvatinib and Capecitabine in Patients With Advanced Malignancies — WITHDRAWN · PHASE1

Refine this search